ITMN Financial Facts
Actimmune: 10.53MCost of goods sold: 2.38M
See Full Income Statement
Additional paid-in capital: 1.31B
Total liabilities and stockholders' equity: 501.68M
See Full Balance Sheet
Earnings History for InterMune Inc. (ITMN)
|
Expand Research on ITMN
| Next EPS Date | 10/25/12 | EPS Growth Rate | -33.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -53.4% | Revenue Growth Rate | +16.2% |
| Average % Move 1-Wk after EPS | -5.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/13  |
 |
Q113 | -$0.65 | -$0.74 | +$0.09 | $10.5M | $10.53M | N/A / N/A | N/A | +7.6% | Details |
| 2/7/13 |
|
Q412 | N/A | -$0.87 | N/A | N/A | $8.31M | N/A / N/A | N/A | N/A | N/A |
| 2/21/13 |
|
Q412 | -$0.90 | -$0.87 | -$0.03 | $8.2M | $8.31M | N/A / N/A | N/A | +16.3% | Details |
| 10/25/12 |
Q312 | N/A | -$0.84 | N/A | N/A | $6.2M | N/A / N/A | N/A | N/A | N/A | |
| 11/7/12 |
|
Q312 | -$0.70 | -$0.84 | +$0.14 | $7.5M | $6.16M | N/A / N/A | N/A | +23.3% | Details |
| 7/23/12 |
Q212 | -$0.78 | -$0.23 | -$0.55 | $5.54M | $39.99M | N/A / N/A | N/A | -14.6% | Details | |
| 4/26/12 |
|
Q112 | -$0.74 | -$0.69 | -$0.05 | $8.9M | $10.77M | N/A / N/A | N/A | -19.7% | Details |
| 2/9/12 |
|
Q411 | -$0.69 | -$0.71 | +$0.02 | $7.81M | $7.88M | N/A / N/A | N/A | -35.3% | Details |
